Interventions for unresectable intrahepatic cholangiocarcinoma: a network meta-analysis

Andrew Tran; Menelaos Konstantinidis; John Moon; Noura El Sehemawi; Katya Ferreira; Peiman Habibollahi; Bruno C. Odisio; Sahar Nourouzpour; Ali Bassir; Nariman Nezami

doi:10.1002/14651858.CD015159

Interventions for unresectable intrahepatic cholangiocarcinoma: a network meta-analysis

Andrew Tran, Menelaos Konstantinidis, John Moon, Noura El Sehemawi, Katya Ferreira, Peiman Habibollahi, Bruno C. Odisio, Sahar Nourouzpour, Ali Bassir, Nariman Nezami

Interventional Radiology

Research output: Contribution to journal › Article › peer-review

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To establish the existence of differences in effectiveness and safety of intra-arterial therapies (IATs) such as bland embolisation, conventional transarterial chemoembolisation (cTACE), drug-eluting bead transarterial chemoembolisation (DEBTACE), yttrium-90 (Y90), hepatic artery infusion (HAI), external beam radiotherapies (EBRTs), and immunotherapy versus systemic chemotherapy for unresectable intrahepatic cholangiocarcinoma through pairwise meta-analysis and network meta-analysis with subsequent treatment ranking.

Original language	English (US)
Article number	CD015159
Journal	Cochrane Database of Systematic Reviews
Volume	2022
Issue number	12
DOIs	https://doi.org/10.1002/14651858.CD015159
State	Published - Dec 8 2022

ASJC Scopus subject areas

Pharmacology (medical)

Access to Document

10.1002/14651858.CD015159

Cite this

@article{e11ff36c7b1c4a48bb08e1d435e5d6c4,

title = "Interventions for unresectable intrahepatic cholangiocarcinoma: a network meta-analysis",

abstract = "Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To establish the existence of differences in effectiveness and safety of intra-arterial therapies (IATs) such as bland embolisation, conventional transarterial chemoembolisation (cTACE), drug-eluting bead transarterial chemoembolisation (DEBTACE), yttrium-90 (Y90), hepatic artery infusion (HAI), external beam radiotherapies (EBRTs), and immunotherapy versus systemic chemotherapy for unresectable intrahepatic cholangiocarcinoma through pairwise meta-analysis and network meta-analysis with subsequent treatment ranking.",

author = "Andrew Tran and Menelaos Konstantinidis and John Moon and {El Sehemawi}, Noura and Katya Ferreira and Peiman Habibollahi and Odisio, {Bruno C.} and Sahar Nourouzpour and Ali Bassir and Nariman Nezami",

note = "Publisher Copyright: Copyright {\textcopyright} 2022 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.",

year = "2022",

month = dec,

day = "8",

doi = "10.1002/14651858.CD015159",

language = "English (US)",

volume = "2022",

journal = "Cochrane Database of Systematic Reviews",

issn = "1465-1858",

publisher = "John Wiley and Sons Ltd",

number = "12",

}

TY - JOUR

T1 - Interventions for unresectable intrahepatic cholangiocarcinoma

T2 - a network meta-analysis

AU - Tran, Andrew

AU - Konstantinidis, Menelaos

AU - Moon, John

AU - El Sehemawi, Noura

AU - Ferreira, Katya

AU - Habibollahi, Peiman

AU - Odisio, Bruno C.

AU - Nourouzpour, Sahar

AU - Bassir, Ali

AU - Nezami, Nariman

PY - 2022/12/8

Y1 - 2022/12/8

N2 - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To establish the existence of differences in effectiveness and safety of intra-arterial therapies (IATs) such as bland embolisation, conventional transarterial chemoembolisation (cTACE), drug-eluting bead transarterial chemoembolisation (DEBTACE), yttrium-90 (Y90), hepatic artery infusion (HAI), external beam radiotherapies (EBRTs), and immunotherapy versus systemic chemotherapy for unresectable intrahepatic cholangiocarcinoma through pairwise meta-analysis and network meta-analysis with subsequent treatment ranking.

AB - Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To establish the existence of differences in effectiveness and safety of intra-arterial therapies (IATs) such as bland embolisation, conventional transarterial chemoembolisation (cTACE), drug-eluting bead transarterial chemoembolisation (DEBTACE), yttrium-90 (Y90), hepatic artery infusion (HAI), external beam radiotherapies (EBRTs), and immunotherapy versus systemic chemotherapy for unresectable intrahepatic cholangiocarcinoma through pairwise meta-analysis and network meta-analysis with subsequent treatment ranking.

UR - http://www.scopus.com/inward/record.url?scp=85143711261&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85143711261&partnerID=8YFLogxK

U2 - 10.1002/14651858.CD015159

DO - 10.1002/14651858.CD015159

M3 - Article

AN - SCOPUS:85143711261

SN - 1465-1858

VL - 2022

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

IS - 12

M1 - CD015159

ER -

Interventions for unresectable intrahepatic cholangiocarcinoma: a network meta-analysis

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this